Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.13.39 extracted from

  • McMillan, K.; Adler, M.; Auld, D.S.; Baldwin, J.J.; Blasko, E.; Browne, L.J.; Chelsky, D.; Davey, D.; Dolle, R.E.; Eagen, K.A.; Erickson, S.; Feldman, R.I.; Glaser, C.B.; Mallari, C.; Morrissey, M.M.; Ohlmeyer, M.H.J.; Pan, G.; Parkinson, J.F.; Phillips, G.B.; Polokoff, M.A.; Sigal, N.H.; Vergona, R.; Whitlow, M.; Young, T.A.; Devlin, J.J
    Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry (2000), Proc. Natl. Acad. Sci. USA, 97, 1506-1511.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 1.14.13.39

Cloned(Commentary)

Cloned (Comment) Organism
expression of His-tagged NOS oxygenase domain lacking the N-terminal 114 residues in Escherichia coli Mus musculus

Crystallization (Commentary)

Crystallization (Comment) Organism
orthorhombic crystals from NOS oxygenase domain lacking the N-terminal 114 residues, preparation in presence of imidazole, structure analysis via x-ray diffraction, also with bound inhibitor N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide Mus musculus

Protein Variants

Protein Variants Comment Organism
additional information monomers encoding NOS oxygenase domain lacking the N-terminal 114 residues, His-tagged, expression in Escherichia coli Mus musculus

Inhibitors

Inhibitors Comment Organism Structure
N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide inhibition of dimer formation in vivo and in vitro, efficiency is dependent on enzyme source Mus musculus

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
2 L-arginine + 3 NADPH + 4 O2 + 3 H+ Homo sapiens
-
 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O
-
 ?
2 L-arginine + 3 NADPH + 4 O2 + 3 H+ Mus musculus
-
 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O
-
 ?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
 inducible
-
Mus musculus P29477 cytokine-inducible in macrophage
-

Source Tissue

Source Tissue Comment Organism Textmining
glioblastoma cell cell line A-172, american type Homo sapiens
-
macrophage
-
 Homo sapiens
-
macrophage RAW 264.7 cells Mus musculus
-
macrophage cytokine-activated Mus musculus
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2 L-arginine + 3 NADPH + 4 O2 + 3 H+
-
 Homo sapiens 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O
-
 ?
2 L-arginine + 3 NADPH + 4 O2 + 3 H+
-
 Mus musculus 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O
-
 ?
2 L-arginine + 3 NADPH + 4 O2 + 3 H+ dimeric structure is required for enzyme activity Mus musculus 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O
-
 ?
oxidized cytochrome c + NADPH + O2
-
 Homo sapiens reduced cytochrome c + NADP+ + H2O
-
 ?
oxidized cytochrome c + NADPH + O2
-
 Mus musculus reduced cytochrome c + NADP+ + H2O
-
 ?

Cofactor

Cofactor Comment Organism Structure
NADPH
-
 Homo sapiens
NADPH
-
 Mus musculus

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.0000022
-
 N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide
-
 Mus musculus